Feature | July 15, 2007| Cristen C. Bolan

CMS Questions CTA’s Adoption for CAD

Guest Editor for Diagnostic & Invasive Cardiology

In the new order of the day, many experts believe that CT angiography (CTA) will replace invasive cardiac catheterization as the primary diagnostic tool for detecting coronary artery disease (CAD) and disorders. This notion has been backed by heavy investments from vendors in clinical trials that may shore up supporting data.
Recently, Toshiba launched one of the largest clinical trials to date, the Toshiba CorE 64 trial, to evaluate the use of 64-slice CT technology. One of the trial’s objectives is to determine if CT could be a diagnostic alternative to cardiac catheterization. If the results prove to be in CT’s favor, trials like this may be justification enough for cardiac CTA to become the gold standard for diagnosing CAD.
But before you write off cardiac catheterization, the Centers for Medicare and Medicaid Services (CMS) is not yet convinced. CMS considers substituting cardiac cath with CTA potentially risky due to the lack of clinical data supporting positive patient outcomes, and, on June 13 of this year, it initiated a National Coverage Analysis (NCA) regarding CTA. CMS states on its Web site (http://www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=206) that while “[p]roponents have claimed that the use of cardiac CTA will lead to better health outcomes and a reduction in cardiac catheterization, the current standard for diagnosis of coronary artery disease…CMS is concerned that despite the lack of clinical evidence to demonstrate improved patient health outcomes with CTA, the procedure has been rapidly adopted by the clinical community.”
CMS indicates that the NCA will evaluate the available evidence for CTA when used to diagnose CAD to determine if a national coverage determination (NCD) is warranted. Plus, the organization has called out for public comments and clinical studies that evaluate CTA technology.
CMS has given the public and the industry 30 days to respond before deciding on whether the situation merits the proposed NCD. So before you substitute cardiac cath with CTA, you might want to wait a few days.

We welcome your comments on the topics found in Diagnostic & Invasive Cardiology.
Please send your thoughts to [email protected]
Please send press releases to [email protected]
and chart responses to [email protected]

Related Content

HeartFlow, FFR-CT Analysis, next-generation platform, second FDA clearance
Technology | CT Angiography (CTA)| June 29, 2016
HeartFlow Inc. announced that it is launching its next generation of the HeartFlow FFR-CT Analysis. The result of years...
CAD-RADS, coronary CT angiography, CCTA, reporting, SCCT, ACR, NASCI, ACC

A coronary CTA scan from a Philips CT scanner illustrating a curved multiplaner reconstruction showing a large occlusion of the artery. 

News | CT Angiography (CTA)| June 17, 2016
Three medical professional societies this week jointly released a new reporting system to standardize reporting of...
Toshiba, Infinix 4-D CT, first U.S. install, Arkansas cancer center
News | CT Angiography (CTA)| May 26, 2016
Cancer patients at the Carti Cancer Center, Little Rock, Ark., now have access to the latest innovation in diagnostic...
HeartFlow, FFR-CT, ruptured coronary plaques, EMERALD study, EuroPCR 2016
News | CT Angiography (CTA)| May 23, 2016
First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may help predict...
Radiation dose management, radiation dose monitoring, X-ray dose

Analytics from Sectra’s radiation dose monitoring software showing procedures where dose levels were higher than normal for various X-ray modalities. 

Feature | Radiation Dose Management| May 12, 2016 | Lori Webb, R.T. (R) and Tom Watson, RCVT
Healthcare organizations, clinicians and medical equipment manufacturers have long focused on the management and redu
FFR-CT, heartflow
Feature | CT Angiography (CTA)| April 15, 2016 | Jeff Zagoudis
Fractional flow reserve-computed tomography (FFR-CT) is still in the early stages of clinical implementation in the U
TAVR runoff image

A 3-D CT reconstruction of a TAVR run-off image to assess the femoral access route using Toshiba's Aquillion One and Vital Images advanced visualization technologies. 

Feature | Heart Valve Technology| April 15, 2016
April 15, 2016 — Accurate and precise anatomical information is crucial to successful transcatheter aortic valve repl
Sponsored Content | Videos | CT Angiography (CTA)| April 12, 2016
A discussion on the adoption rate of FFR-CT with Dr. Campbell Rogers, chief medical officer of HeartFlow.
FFR-CT, HeartFlow, PLATFORM trial, one-year results, ACC 2016
News | CT Angiography (CTA)| April 05, 2016
Novel technology developed by HeartFlow Inc. significantly reduces the need for invasive procedures to diagnose...
Overlay Init